Friday, March 24, 2023


Pangaea’s Novel AI Predicts Length-of-Stay & Risk of Mortality for Patients in the ICU

Pangaea Data, provider of a novel Artificial Intelligence (AI)-driven product for characterizing patients by mapping their journey and disease trajectories in a privacy-preserving and...

Maze Therapeutics Announces New Clinical Data Supporting MZE001 as a Potential Treatment for Pompe Disease

Maze Therapeutics, a company translating genetic insights into new precision medicines, to announced new data from an exploratory muscle biopsy cohort of its Phase...

Amwell Expands Digital Clinical Programs Through Partnership with DarioHealth

Amwell, a leader in digital healthcare enablement, announced the expansion of its digital clinical programs to include a cardiometabolic program, enabling health plans and...

OakWell Launches to Provide High-Quality Primary Care Directly to Kidney Patients in Dialysis Centers

Oak Street Health, a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP...

Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome

Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the U.S. Food and Drug...

Hot Topics